For decades, Cochrane — formerly called the Cochrane Collaboration — has been known internationally for its systematic reviews of medical treatments and interventions. Now the U.K.-based charity is under fire for its clumsy handling of a thorny issue: the status of a flawed 2019 review of exercise therapy for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).| The Sick Times - Chronicling the Long Covid crisis
The decision to abandon a process to re-evaluate a review recommending exercise therapy for chronic fatigue syndrome (ME/CFS) has reignited calls for the article to be withdrawn. The 2019 ver…| Retraction Watch
Today, the Independent Advisory Group (IAG) sent the submission below to the Cochrane Editorial Board, copied to the Governing Board. This is the second of three recent actions by the IAG: January …| Project Talk Page
A process I’ve been involved with at a journal recently exploded. It was meant to resolve a controversy about a publication, not…| Absolutely Maybe
By David Tuller, DrPH| Trial By Error
By David Tuller, DrPH I have written frequently about Cochrane, the organization renowned for its systematic reviews of medical interventions, and its deepl ...| Virology Blog
By David Tuller, DrPH| Trial By Error
Cochrane: Withdraw the harmful 2019/2024 Exercise therapy for CFS review| Change.org
By David Tuller, DrPH Cochrane has just given the finger to the international ME/CFS community. After jerking everyone around and promising for five years t ...| Virology Blog